Margaret Macmillan is an Oncology physician. ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2450 Riverside Ave SE
East Building Journey Clinic 9e
Minneapolis, MN 55454
Telephone
612-365-8100Registry record last updated 11 Apr 2012.
Clinical trials
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Sponsor: Masonic Cancer Center, University of Minnesota
- Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Sponsor: Fred Hutchinson Cancer Center
- Gene Therapy for Fanconi Anemia, Complementation Group A
Sponsor: Rocket Pharmaceuticals Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20254 payments$36,407openpaymentsdata.cms.gov ↗
- National Marrow Donor ProgramProgram year20245 payments$36,180openpaymentsdata.cms.gov ↗
- JAZZ PHARMACEUTICALS INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
University of Minnesota
FY2023$184,800UG1HL069290 - Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD
University of Minnesota
FY2016$537,191R01HL114512
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”